Group items tagged

“We’re in a new world in terms of the way healthcare is going to be practiced, based upon these data-driven insights.” A future which combines both evidence-based and practice-based medicine is likely to produce the best outcomes for patients

In January, the biotech company Genentech reportedly committed $10 million for access to the DNA of 3,000 Parkinson’s patients and their families. A week later, Pfizer made a similar deal for the genomes of 5,000 people with lupus.

A trove of data could give scientists the tools they need to develop gene-specific drug therapies for certain diseases. “We are hoping to ultimately develop Parkinson’s medicines, for example, that actually modify the disease as opposed to just treating symptoms,”

“this has the possibility of not only helping us find new cures, but it also helps us create a genuine health care system as opposed to just a disease care system.”

The Obama administration has called for a new era of "personalized medicine," which relies on collecting a vast amount of genetic information from American volunteers to bolster the development of genetics-based treatment.

. Medical schools did not pay much heed to genetics until relatively recently

Studies have also found that most patients don't actually change their behavior for the better once they learn about a genetic predisposition to a disease. But he also argues that primary care physicians shouldn't simply ignore genetics.

L’Oreal makes cosmetics and hair color. It also makes skin

Now it’s talking about

printing

Researchers from Florida Atlantic University have created a sensitive film that can detect viruses and bacteria, such as HIV and Staph, at home.

Все генетические заболевания, онкология, старение — все это так или иначе связано с повреждениями в ДНК, которые неизбежно возникают при репликации, и накапливаются в течение жизни. А система репарации ДНК, за исследование которой дали премию, — это то, что позволяет с такими повреждениями бороться.

Медицинские перспективы этих открытий в том, что они дают возможность создания лекарств против болезней, связанных с нарушениями и повреждениями в ДНК.